Structure-Based Discovery of M-89 as a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein–Protein Interaction

Aguilar, Angelo; Zheng, Ke; Xu, Tianfeng; Xu, Shilin; Huang, Liyue; Fernandez-Salas, Ester; Liu, Liu; Bernard, Denzil; Harvey, Kaitlin P.; Foster, Caroline; McEachern, Donna; Stuckey, Jeanne; Chinnaswamy, Krishnapriya; Delproposto, James; Kampf, Jeff W.; Wang, Shaomeng

doi:10.1021/acs.jmedchem.9b00021

Title: Structure-Based Discovery of M-89 as a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein–Protein Interaction

Journal Article · 22 June 2019 · Journal of Medicinal Chemistry

DOI: https://doi.org/10.1021/acs.jmedchem.9b00021 · OSTI ID:1544865

Aguilar, Angelo ^[1]; Zheng, Ke ^[2]; Xu, Tianfeng ^[1]; Xu, Shilin ^[1]; Huang, Liyue ^[1]; Fernandez-Salas, Ester ^[1]; Liu, Liu ^[1]; Bernard, Denzil ^[1]; Harvey, Kaitlin P. ^[1]; Foster, Caroline ^[1]; McEachern, Donna ^[1]; Stuckey, Jeanne ^[1]; Chinnaswamy, Krishnapriya ^[1]; Delproposto, James ^[1]; Kampf, Jeff W. ^[1];

^[1]

Univ. of Michigan, Ann Arbor, MI (United States)
Univ. of Michigan, Ann Arbor, MI (United States); Sichuan Univ., Chengdu (China)

Inhibition of the menin-mixed lineage leukemia (MLL) protein–protein interaction is a promising new therapeutic strategy for the treatment of acute leukemia carrying MLL fusion (MLL leukemia). We describe herein our structure-based design, synthesis, and evaluation of a new class of small-molecule inhibitors of the menin-MLL interaction (hereafter called menin inhibitors). Our efforts have resulted in the discovery of highly potent menin inhibitors, as exemplified by compound 42 (M-89). M-89 binds to menin with a K_d value of 1.4 nM and effectively engages cellular menin protein at low nanomolar concentrations. M-89 inhibits cell growth in the MV4;11 and MOLM-13 leukemia cell lines carrying MLL fusion with IC₅₀ values of 25 and 55 nM, respectively, and demonstrates >100-fold selectivity over the HL-60 leukemia cell line lacking MLL fusion. The determination of a co-crystal structure of M-89 in a complex with menin provides the structural basis for their high-affinity interaction. Overall, we conclude that further optimization of M-89 may lead to a new class of therapy for the treatment of MLL leukemia.

View Accepted Manuscript (DOE)

Cite

Export

Save

Research Organization:: Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: USDOE; National Institutes of Health (NIH); Michigan Economic Development Corporation

Grant/Contract Number:: R01CA208267; P30 CA046592; AC02-06CH11357; 085P1000817

OSTI ID:: 1544865

Journal Information:: Journal of Medicinal Chemistry, Vol. 62, Issue 13; ISSN 0022-2623

Publisher:: American Chemical Society (ACS)Copyright Statement

Country of Publication:: United States

Language:: ENGLISH

Citation Metrics:

Cited by: 17 works

Citation information provided by
Web of Science

References (31)

The role of MLL in hematopoiesis and leukemia Ernst, Patricia; Wang, Jing; Korsmeyer, Stanley J. Current Opinion in Hematology, Vol. 9, Issue 4 https://doi.org/10.1097/00062752-200207000-00004	journal	January 2002
Mechanisms of leukemogenesis by MLL fusion proteins: Review Marschalek, Rolf British Journal of Haematology, Vol. 152, Issue 2 https://doi.org/10.1111/j.1365-2141.2010.08459.x	journal	December 2010
MLL: How complex does it get? Popovic, Relja; Zeleznik-Le, Nancy J. Journal of Cellular Biochemistry, Vol. 95, Issue 2 https://doi.org/10.1002/jcb.20430	journal	January 2005
When epigenetics kills: MLL fusion proteins in leukemia Slany, Robert K. Hematological Oncology, Vol. 23, Issue 1 https://doi.org/10.1002/hon.739	journal	March 2005
Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group Tomizawa, D.; Koh, K.; Sato, T. Leukemia, Vol. 21, Issue 11 https://doi.org/10.1038/sj.leu.2404903	journal	August 2007
Chromosomal Aberration of the 11q23 Locus in Acute Leukemia and Frequency of MLL Gene Translocation : Results in 378 Adult Patients Cox, M. Christina; Panetta, Paola; Lo-Coco, Francesco American Journal of Clinical Pathology, Vol. 122, Issue 2 https://doi.org/10.1309/RX27R8GJQM330C22	journal	August 2004
MLL rearrangements in haematological malignancies: lessons from clinical and biological studies DiMartino, Jorge F.; Cleary, Michael L. British Journal of Haematology, Vol. 106, Issue 3 https://doi.org/10.1046/j.1365-2141.1999.01439.x	journal	September 1999
The molecular biology of mixed lineage leukemia Slany, R. K. Haematologica, Vol. 94, Issue 7 https://doi.org/10.3324/haematol.2008.002436	journal	June 2009
Disordered epigenetic regulation in MLL-related leukemia Zhang, Yue; Chen, Aili; Yan, Xiao-Mei International Journal of Hematology, Vol. 96, Issue 4 https://doi.org/10.1007/s12185-012-1180-0	journal	September 2012
MLL: a histone methyltransferase disrupted in leukemia Hess, Jay L. Trends in Molecular Medicine, Vol. 10, Issue 10 https://doi.org/10.1016/j.molmed.2004.08.005	journal	October 2004
MLL translocations, histone modifications and leukaemia stem-cell development Krivtsov, Andrei V.; Armstrong, Scott A. Nature Reviews Cancer, Vol. 7, Issue 11 https://doi.org/10.1038/nrc2253	journal	November 2007
Interaction of MLL Amino Terminal Sequences with Menin Is Required for Transformation Caslini, C.; Yang, Z.; El-Osta, M. Cancer Research, Vol. 67, Issue 15 https://doi.org/10.1158/0008-5472.CAN-06-2369	journal	August 2007
Menin Critically Links MLL Proteins with LEDGF on Cancer-Associated Target Genes Yokoyama, Akihiko; Cleary, Michael L. Cancer Cell, Vol. 14, Issue 1 https://doi.org/10.1016/j.ccr.2008.05.003	journal	July 2008
The Menin Tumor Suppressor Protein Is an Essential Oncogenic Cofactor for MLL-Associated Leukemogenesis Yokoyama, Akihiko; Somervaille, Tim C. P.; Smith, Kevin S. Cell, Vol. 123, Issue 2 https://doi.org/10.1016/j.cell.2005.09.025	journal	October 2005
The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression Chen, Y. -X.; Yan, J.; Keeshan, K. Proceedings of the National Academy of Sciences, Vol. 103, Issue 4 https://doi.org/10.1073/pnas.0510347103	journal	January 2006
Challenges and opportunities in targeting the menin–MLL interaction Cierpicki, Tomasz; Grembecka, Jolanta Future Medicinal Chemistry, Vol. 6, Issue 4 https://doi.org/10.4155/fmc.13.214	journal	March 2014
The same pocket in menin binds both MLL and JUND but has opposite effects on transcription Huang, Jing; Gurung, Buddha; Wan, Bingbing Nature, Vol. 482, Issue 7386 https://doi.org/10.1038/nature10806	journal	February 2012
Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leukemia Shi, Aibin; Murai, Marcelo J.; He, Shihan Blood, Vol. 120, Issue 23 https://doi.org/10.1182/blood-2012-05-429274	journal	November 2012
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia Grembecka, Jolanta; He, Shihan; Shi, Aibin Nature Chemical Biology, Vol. 8, Issue 3 https://doi.org/10.1038/nchembio.773	journal	January 2012
High-Affinity Small-Molecule Inhibitors of the Menin-Mixed Lineage Leukemia (MLL) Interaction Closely Mimic a Natural Protein–Protein Interaction He, Shihan; Senter, Timothy J.; Pollock, Jonathan Journal of Medicinal Chemistry, Vol. 57, Issue 4 https://doi.org/10.1021/jm401868d	journal	February 2014
Property Focused Structure-Based Optimization of Small Molecule Inhibitors of the Protein–Protein Interaction between Menin and Mixed Lineage Leukemia (MLL) Borkin, Dmitry; Pollock, Jonathan; Kempinska, Katarzyna Journal of Medicinal Chemistry, Vol. 59, Issue 3 https://doi.org/10.1021/acs.jmedchem.5b01305	journal	January 2016
Complexity of Blocking Bivalent Protein–Protein Interactions: Development of a Highly Potent Inhibitor of the Menin–Mixed-Lineage Leukemia Interaction Borkin, Dmitry; Klossowski, Szymon; Pollock, Jonathan Journal of Medicinal Chemistry, Vol. 61, Issue 11 https://doi.org/10.1021/acs.jmedchem.8b00071	journal	May 2018
Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo Borkin, Dmitry; He, Shihan; Miao, Hongzhi Cancer Cell, Vol. 27, Issue 4 https://doi.org/10.1016/j.ccell.2015.02.016	journal	April 2015
Menin-MLL inhibitors block oncogenic transformation by MLL-fusion proteins in a fusion partner-independent manner He, S.; Malik, B.; Borkin, D. Leukemia, Vol. 30, Issue 2 https://doi.org/10.1038/leu.2015.144	journal	June 2015
Design of the First-in-Class, Highly Potent Irreversible Inhibitor Targeting the Menin-MLL Protein-Protein Interaction Xu, Shilin; Aguilar, Angelo; Xu, Tianfeng Angewandte Chemie International Edition, Vol. 57, Issue 6 https://doi.org/10.1002/anie.201711828	journal	January 2018
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay Molina, Daniel Martinez; Jafari, Rozbeh; Ignatushchenko, Marina Science, Vol. 341, Issue 6141 https://doi.org/10.1126/science.1233606	journal	July 2013
The cellular thermal shift assay for evaluating drug target interactions in cells Jafari, Rozbeh; Almqvist, Helena; Axelsson, Hanna Nature Protocols, Vol. 9, Issue 9 https://doi.org/10.1038/nprot.2014.138	journal	August 2014
Structure-Based Design of High-Affinity Macrocyclic Peptidomimetics to Block the Menin-Mixed Lineage Leukemia 1 (MLL1) Protein–Protein Interaction Zhou, Haibin; Liu, Liu; Huang, Jing Journal of Medicinal Chemistry, Vol. 56, Issue 3 https://doi.org/10.1021/jm3015298	journal	January 2013
Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization Nikolovska-Coleska, Zaneta; Wang, Renxiao; Fang, Xueliang Analytical Biochemistry, Vol. 332, Issue 2 https://doi.org/10.1016/j.ab.2004.05.055	journal	September 2004
MOLREP an Automated Program for Molecular Replacement Vagin, A.; Teplyakov, A. Journal of Applied Crystallography, Vol. 30, Issue 6, p. 1022-1025 https://doi.org/10.1107/S0021889897006766	journal	December 1997
Coot model-building tools for molecular graphics Emsley, Paul; Cowtan, Kevin Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132 https://doi.org/10.1107/S0907444904019158	journal	November 2004

Cited By (1)

Correction to: The design and development of covalent protein-protein interaction inhibitors for cancer treatment Cheng, Sha-Sha; Yang, Guan-Jun; Wang, Wanhe Journal of Hematology & Oncology, Vol. 13, Issue 1 https://doi.org/10.1186/s13045-020-00938-7	journal	July 2020

Similar Records

Design of the First‐in‐Class, Highly Potent Irreversible Inhibitor Targeting the Menin‐MLL Protein–Protein Interaction

Journal Article · 2018 · Angewandte Chemie · OSTI ID:1416993

Xu, Shilin; Aguilar, Angelo; Xu, Tianfeng; +12 more

Design of the First-in-Class, Highly Potent Irreversible Inhibitor Targeting the Menin-MLL Protein–Protein Interaction

Journal Article · 2017 · Angewandte Chemie (International Edition) · OSTI ID:1438913

Xu, Shilin; Aguilar, Angelo; Xu, Tianfeng; +12 more

Complexity of Blocking Bivalent Protein–Protein Interactions: Development of a Highly Potent Inhibitor of the Menin–Mixed-Lineage Leukemia Interaction

Journal Article · 2018 · Journal of Medicinal Chemistry · OSTI ID:1544860

Borkin, Dmitry; Klossowski, Szymon; Pollock, Jonathan; +10 more

Related Subjects

60 APPLIED LIFE SCIENCES

Title: Structure-Based Discovery of M-89 as a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein–Protein Interaction

Citation Formats

References (31)

Cited By (1)

Linked Research (1)

Similar Records

Related Subjects